RR6 prognostic model provides information about survival for myelofibrosis treated with ruxolitinib: validation in a real-life cohortEmilia Scalzulli,Claudia Ielo,Cristina Luise, Paolo Musiu, Maria L Bisegna,Ida Carmosino,Giovanni M Assanto,Maurizio Martelli,Massimo BrecciaBlood Advances(2022)引用 7|浏览6暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要